Siliconinvestor nnvc

Feb 23, 2021 · NanoViricides Inc. NYSEMkt Updated Feb 23, 2021 9:00 PM NNVC 4.28 0.34 (7.36%). 11,040

Stock discussion and message boards for investors. We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. Find the latest NanoViricides, Inc. (NNVC) stock quote, history, news and other vital information to help you with your stock trading and investing. NanoViricides Inc. NYSEMkt Updated Feb 23, 2021 9:00 PM NNVC 4.28 0.34 (7.36%). 11,040 NNVC News: NanoViricides reports FQ2 results: 02/17/2021 06:28:57 AM: NNVC News: Quarterly Report (10-q) 02/16/2021 04:40:48 PM: NNVC News: Amended Statement of Ownership (sc 13g/a) 02/16/2021 09:48:43 AM: NNVC News: NanoViricides's Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP..C Find real-time NNVC - NanoViricides Inc stock quotes, company profile, news and forecasts from CNN Business. NNVC Stock Message Board for Investors.

11.04.2021 Siliconinvestor nnvc

NanoViricides Inc Stock Price, News and Company Updates. Message Board Total Posts: 84 A high-level overview of NanoViricides, Inc. (NNVC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. NNVC:US-7.36%. Sector. Health Care +0.28%.

NanoViricides, Inc. Appoints Dr. Mark Day to its Board of Directors . via: PR Newswire at 2019-06-10 03:00:00:000. SHELTON, Conn. , June 10, 2019 /PRNewswire/ -- NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, reports that Dr. Mark Day has been duly appointed as an Independent Director to its Board of Directors, effecti…

NanoViricides, Inc. (NNVC) 8d ago, source: Yahoo Finance. SHELTON, CT / ACCESSWIRE / January 27, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective broad-spectrum antiviral therapies Get the latest updated list of insiders for NanoViricides, Inc. (NNVC).

NNVC. 1. NNVC / NanoViricides, Inc. S-1/A - - FORM S-1/A. 2020-01-07 sec.gov - 1 - As filed “NNVC” www.nanoviricides.com November 13, 2014 Via Edgar Only United States Securities Message Board data supplied by SiliconInvestor .

No events in the next 90 days.

NNVC, Nanoviricides Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines NNVC. NNVC. $4.95 -$0.03 -0.6% Price as of February 19, 2021, 9:00 p.m.

Feb 10, 2018 We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still Feb 11, 2018 We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still NNVC - NanoViricides, Inc. NNVC, 4.130, -6.8%, drkaz, 12837, January 30, 1. Eli Lilly · LLY, 203.82, -0.3%, 609, January 29. CRIS, Curis (formerly CBMI) · CRIS Dec 9, 2014 Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade? To: donpat who wrote (3267), 12/9/2014 8:44:18 NNVC / NanoViricides, Inc. Institutional Ownership.

Sponsored By. About NanoViricides Inc NanoViricides, Inc. is a biopharmaceutical company. The Company researches treatments The Silicon Investor messaging board still has some old posts on SALV, Gene's venture prior to NNVC. The link is below. Much like NNVC, SALV was based on a sound idea with great promise. It's just that SALV was not able to run with it.

Page created - August 27, 2011. People. 358 likes. Related Pages.

Fire Stables. Wedding Venue. Founded in 1995, SI is one of the oldest and best-known financial forums around. SI was the first Internet community. SI has an immensely desirable demograph ic (wealthy folks who manage their own investments, often for a living), and is presently undergoing a modernization to welcome in and provide a home for the next great generation of investors, analysts and friends. NNVC:US-7.36%.

průvodce likvidací pro ředitele
hodnota 2 euromincí v amerických dolarech
apple id nemůže ověřit, že vypršel časový limit relace identity
accenture capgemini
bitcoin je stále nízký
nákup kreditní kartou

Feb 11, 2018 We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still

NanoViricides Inc. NNVC Stock Message Board: That post on silicon investor was a lengthy NNVC doesn't own anything of substance. His two other companies own all the IP and patents. NNVC licenses the so called technology from a company he owns. Your stock proceeds just fund he and his NNVC - Silicon Investor. Siliconinvestor.com NanoViricides Has Filed Annual Report, Says Company Has Sufficient Cash To Advance Into Clinical Trials SHELTON, CONNECTICUT -- Friday, September, 29, 2017 -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), reports that it has filed its financial year end annual report (Form 10-K) with the Securities and Exchange Commission (SEC) on Thursday NNVC / NanoViricides, Inc. S-1 - Registration Statement - FORM S-1 2019-09-30 sec.gov - 15 - As filed with the Securities and Exchange Commission on September 27, 2019 Registration No. NNVC NNVC NanoViricides Inc: Rawnoc passed: Obit: https://www.siliconinvestor.com/readmsg.aspx?msgid=31736333 - #5182444 NNVC News: Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants: 01/27/2021 07:00:00 AM: NNVC News: Amended Statement of Ownership (sc 13g/a) 01/26/2021 11:05:24 AM: NNVC News: Amended Statement of Ownership (sc 13g/a) 01/04/2021 11:45:37 AM: NNVC News: Current Report Filing (8-k) 12/10/2020 04:31 Investor Relations Institutional Ownership and Shareholders NanoViricides, Inc. (US:NNVC) has 45 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 853,387 shares. Pause Threshold Price.